• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.

作者信息

Seydel W, Stang E, Roos N, Krause J

机构信息

Dr. Karl Thomae GmbH, A Biochemische Forschung, Biberach an der Riss, Fed. Rep. of Germany.

出版信息

Arzneimittelforschung. 1991 Feb;41(2):182-6.

PMID:1904231
Abstract

The glycoprotein tissue-type plasminogen activator (t-PA, alteplase, CAS 105857-23-6) is a serine protease consisting of 527 amino acids and can activate plasminogen to plasmin, which subsequently dissolves the fibrin network of a thrombus. This activation occurs selectively on the thrombus, making recombinant t-PA a very effective agent in the treatment of thromboembolic disorders. t-PA has a short in vivo half-life and is rapidly removed from the circulation by the liver. The catabolism of t-PA involves receptor-mediated endocytosis and intracellular degradation in several cell types of the liver namely hepatic endothelial, parenchymal and Kupffer cells. Liver endothelial cells have been reported to possess a specific uptake system for t-PA based on the recognition of the high mannose carbohydrate structures on Asn117. To further elucidate the involvement of the mannose receptor on sinusoidal endothelial cells in the hepatic catabolism of t-PA and to identify the mechanisms involved, biochemical as well as electron microscopic studies were performed. The biochemical studies revealed that the removal of the mannose side chain in t-PA significantly reduced its clearance and degradation in isolated perfused livers. The binding of t-PA to preparations of primary hepatocytes and liver cell membranes could not be competed for by various sugars and glycoproteins, and was not dependent on the presence of carbohydrates on the molecule. This ruled out a major relevance of the sugar moieties of t-PA in its recognition by liver cells that were not of endothelial origin.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
Arzneimittelforschung. 1991 Feb;41(2):182-6.
2
The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.低密度脂蛋白受体相关蛋白(LRP)在大鼠体内重组单链尿激酶型纤溶酶原激活剂的血浆清除及肝脏摄取中的作用
Thromb Haemost. 1997 Apr;77(4):710-7.
3
Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.簇状甘露糖苷可抑制大鼠和人类细胞中甘露糖受体介导的组织型纤溶酶原激活物的降解。
Hepatology. 1997 Nov;26(5):1303-10. doi: 10.1053/jhep.1997.v26.pm0009362376.
4
Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.组织型纤溶酶原激活剂与1型纤溶酶原激活剂抑制剂复合物与大鼠肝细胞相互作用的表征
Thromb Haemost. 1995 Nov;74(5):1298-304.
5
Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.天然和非糖基化重组单链尿激酶型纤溶酶原激活剂被大鼠肝实质细胞上不同的受体系统识别。
Thromb Haemost. 1995 Aug;74(2):722-9.
6
Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits.分离的大鼠肝细胞对重组组织型纤溶酶原激活剂的内化作用是通过有被小窝进行的。
Thromb Haemost. 1990 Apr 12;63(2):251-8.
7
Uptake and degradation of tissue plasminogen activator in rat liver.大鼠肝脏中组织型纤溶酶原激活剂的摄取与降解
Thromb Haemost. 1988 Jun 16;59(3):474-9.
8
Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.肝脏中甘露糖和半乳糖受体对组织型纤溶酶原激活物的清除作用。
Thromb Haemost. 1990 Feb 19;63(1):60-6.
9
Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.组织型纤溶酶原激活剂的药代动力学与肝脏分解代谢
Arzneimittelforschung. 1991 Dec;41(12):1310-9.
10
Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.组织型纤溶酶原激活剂被大鼠肝细胞的甘露糖和半乳糖受体通过胞吞作用摄取。
Thromb Haemost. 1988 Jun 16;59(3):480-4.

引用本文的文献

1
A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.考虑额外生理信息的单物种方法预测糖蛋白衍生治疗药物的肝清除率。
Clin Pharmacokinet. 2011 Oct;50(10):665-74. doi: 10.2165/11592610-000000000-00000.
2
Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo.大鼠肝细胞在体内对组织型纤溶酶原激活剂的内吞作用及细胞内加工过程。
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):841-51. doi: 10.1042/bj2820841.
3
Characterization of the binding of plasminogen activators to plasma membranes from human liver.
纤溶酶原激活剂与人肝细胞膜结合的特性研究
Biochem J. 1992 Nov 1;287 ( Pt 3)(Pt 3):911-5. doi: 10.1042/bj2870911.
4
Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.肝细胞对组织型纤溶酶原激活剂进行非碳水化合物依赖性内吞作用的证据。
Biochem J. 1992 Aug 1;285 ( Pt 3)(Pt 3):799-804. doi: 10.1042/bj2850799.